Hu Yanjie, Yuan Xingzhu, Liang Shiqi, Yang Xiaoling, Luo Yanli, Li Ka
West China School of Nursing, Sichuan University/West China Hospital, Sichuan University, Chengdu 610041, China.
Department of Liver Surgery, West China Hospital/West China School of Nursing, Sichuan University, Chengdu 610041, China.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Jul;54(4):771-776. doi: 10.12182/20230760303.
To explore the predictive effect of preoperative liver function indicators for intraoperative massive blood transfusion in orthotopic liver transplantation and to establish a prediction model.
We retrospectively analyzed the relevant data of 607 patients who underwent orthotopic liver transplantation in the Department of Liver Surgery, West China Hospital, Sichuan University between January 1, 2015 and June 30, 2021. According to the intraoperative transfusion volume of leukocyte-reduced red blood cells in additive solution, the patients were divided into a massive blood transfusion (MBT) group and a non-massive blood transfusion (NMBT) group. Univariate and multivariate logistic regressions were performed to analyze the risk factors of intraoperative MBT in orthotopic liver transplantation, the calibration of the predictive model was assessed by Hosmer-Lemeshow test, and the discrimination power of the predictive model was measured by area under the curve ( ) of the receiver operating characteristic (ROC) curve.
According to the results of logistic regression, alanine transaminase (ALT), aspartate transaminase (AST), total bilirubin (TBIL), direct bilirubin (DBIL), albumin (ALB), and Child-Pugh score showed no correlation with the risk of MBT in orthotopic liver transplantation operation. Platelet count (PLT) (odds ratio [ ]=0.90, 95% confidence interval [ ]: 0.09-0.19, =0.02), international normalized ratio (INR) ( =19.43, 95% : 7.64-19.44, <0.01), prothrombin time (PT) ( =1.43, 95% : 1.25-1.63, <0.01), and activated partial thromboplastin time (APTT) ( =0.92, 95% : 0.90-0.95, <0.01) were identified as the risk factors of intraoperative MBT in orthotopic liver transplantation. The Hosmer-Lemeshow test showed that the predictive model had good calibration ( =9.06, =0.48) and discrimination power ( =0.80, 95% 0.766-0.834, <0.01).
A predictive model based on the preoperative PLT, INR, PT, and APTT of patients undergoing orthotopic liver transplantation was established and can be used to predict the risk of intraoperative MBT in liver transplantation patients.
探讨原位肝移植术中大量输血的术前肝功能指标预测效果并建立预测模型。
回顾性分析2015年1月1日至2021年6月30日在四川大学华西医院肝脏外科接受原位肝移植的607例患者的相关资料。根据术中添加溶液中去白细胞红细胞的输血量,将患者分为大量输血(MBT)组和非大量输血(NMBT)组。采用单因素和多因素logistic回归分析原位肝移植术中MBT的危险因素,通过Hosmer-Lemeshow检验评估预测模型的校准情况,采用受试者操作特征(ROC)曲线下面积( )衡量预测模型的辨别力。
根据logistic回归结果,丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、总胆红素(TBIL)、直接胆红素(DBIL)、白蛋白(ALB)和Child-Pugh评分与原位肝移植手术中MBT风险无相关性。血小板计数(PLT)(比值比[ ]=0.90,95%置信区间[ ]:0.090.19, =0.02)、国际标准化比值(INR)( =19.43,95% :7.6419.44, <0.01)、凝血酶原时间(PT)( =1.43,95% :1.251.63, <0.01)和活化部分凝血活酶时间(APTT)( =0.92,95% :0.900.95, <0.01)被确定为原位肝移植术中MBT的危险因素。Hosmer-Lemeshow检验显示预测模型具有良好的校准( =9.06, =0.48)和辨别力( =0.80,95% 0.766~0.834, <0.01)。
建立了基于原位肝移植患者术前PLT、INR、PT和APTT的预测模型,可用于预测肝移植患者术中MBT的风险。